Arm Lift Surgery (Brachioplasty) in India and UAE | Complete Patient Guide

• IDEAL CANDIDATES:

• Adults with moderate-to-severe upper arm skin laxity (Pittsburgh Rating Scale Grade II, III, or IV) that is unresponsive to conservative skin-tightening modalities

• Post-bariatric surgery patients who have achieved a stable weight for a minimum of 12–18 months following Roux-en-Y gastric bypass, sleeve gastrectomy, or adjustable gastric banding

• Patients with significant weight loss (≥40% excess body weight) through non-surgical means and stable weight for ≥6 months

• Adults ≥18 years of age with realistic expectations about scar outcomes (the medial arm scar is permanent, though it matures and fades significantly over 12–18 months)

• Patients with a BMI ≤32 kg/m² at the time of surgery (higher BMI is associated with increased wound-healing complications; GAF Healthcare's surgical partners may consider up to BMI 35 on a case-by-case basis)

• Non-smokers or patients who have ceased smoking for ≥6 weeks preoperatively (nicotine impairs microvasculature and dramatically increases wound dehiscence risk)

• REQUIRED PREOPERATIVE DIAGNOSTICS:

• Full Blood Count (FBC) with differential; Comprehensive Metabolic Panel (CMP) including renal and hepatic function

• Coagulation screen: PT, aPTT, INR (mandatory; brachioplasty involves a significant area of dissection)

• Serum albumin and pre-albumin (nutritional status markers—critical in post-bariatric patients; surgery is deferred if albumin <3.0 g/dL)

• Fasting blood glucose and HbA1c (diabetes is a major risk factor for wound breakdown)

• Thyroid function tests (TSH, free T4) to exclude hypothyroidism, which impairs healing

• 12-lead ECG and anaesthetic fitness assessment for all patients ≥40 years or with cardiac history

• Chest X-ray (PA view)

• Doppler ultrasound or duplex scan of upper limb vasculature if lymphoedema or prior axillary surgery (e.g., lymph node dissection for breast cancer) is suspected

• High-resolution photography and standardised arm circumference measurements for surgical planning

• Psychological and body-dysmorphic disorder (BDD) screening using validated tools (e.g., Body Dysmorphic Disorder Questionnaire) per ASPS guidelines

• CONTRAINDICATIONS:

• Active smoker unwilling to cease ≥6 weeks pre- and post-operatively

• Uncontrolled diabetes mellitus (HbA1c >8.0%)

• Documented lymphoedema of the upper extremity (relative contraindication; risk of worsening oedema is high)

• Active or recent (within 5 years) upper extremity malignancy, or history of axillary lymph node dissection with documented lymphatic compromise

• Severe coagulopathy or therapeutic anticoagulation that cannot be safely bridged

• BMI >35 kg/m² (significantly elevated wound complication rate; weight optimisation recommended first)

• Unstable psychiatric illness or unrealistic expectations not resolved through counselling

• Pregnancy or planned pregnancy within 12 months

• Severe cardiopulmonary disease rendering general anaesthesia prohibitively high-risk (ASA Class IV or V)

STANDARD BRACHIOPLASTY TECHNIQUES:

1. Standard Medial Brachioplasty (Traditional Excisional): The workhorse technique for moderate-to-severe laxity. An elliptical wedge of excess skin and subcutaneous fat is excised along the posteromedial arm from the axillary fold to a point proximal to the medial epicondyle of the humerus. The scar is positioned in the brachial sulcus (posteromedial groove) so it rests against the thoracic wall when the arm is adducted, minimising visibility. Deep fascial sutures (typically braided absorbable sutures such as PDS 2-0 or Vicryl) anchor the elevated dermis to the brachial fascia to reduce tension on the skin closure—a technique that significantly improves scar quality and reduces long-term scar widening.

2. Limited-Incision (Mini) Brachioplasty: Indicated for Pittsburgh Grade I–II laxity confined to the axillary region. The incision is hidden entirely within the axillary vault. This technique avoids the longitudinal medial arm scar but provides only modest correction and is inappropriate for patients with significant distal arm redundancy.

3. Extended Brachioplasty (Brachial Torsoplasty): For patients with severe ptosis that extends beyond the arm into the lateral thoracic region, the resection is extended onto the lateral chest wall—often combined with a lateral thigh and trunk lift in the context of post-bariatric total body contouring. This is a significantly more complex operation requiring extended anaesthesia time and meticulous positioning.

4. Liposuction-Assisted Brachioplasty (LAB): In patients with concurrent upper arm lipohypertrophy overlying adequate-quality skin (younger patients, mild laxity), power-assisted liposuction (PAL using devices such as the MicroAire system) or VASER ultrasound-assisted liposuction (UAL) can be performed 3–6 months prior to or simultaneous with formal resection. UAL selectively emulsifies adipocytes while preserving neurovascular structures and has been shown in prospective studies to reduce blood loss and improve skin retraction compared to standard suction-assisted lipectomy.

5. BodyTite-Assisted Brachioplasty (Minimally Invasive Radiofrequency-Assisted Lipolysis, RFAL): BodyTite (InMode) delivers bipolar radiofrequency energy to simultaneously liquefy fat and contract the overlying dermis via internal and external electrodes. This approach is reserved for carefully selected patients with Grade I–II laxity, adequate skin elasticity, and without major ptosis. It results in no external scar but offers more modest skin tightening than formal excision. Many accredited centres in both India and the UAE have integrated BodyTite as a standalone or adjunct to brachioplasty.

6. Combined Body Contouring (Post-Bariatric Sequencing): International consensus guidelines recommend staging body-contouring procedures in post-bariatric patients. Brachioplasty is commonly performed as part of a staged sequence—typically after lower body lift and abdominoplasty—or combined with mastopexy/breast reduction when operative time permits and patient physiology allows. Total operative time for combined procedures is limited to 6–8 hours in most accredited centres to minimise anaesthetic and DVT risk.

ANESTHESIA AND PERIOPERATIVE TECHNOLOGIES:

• Total Intravenous Anaesthesia (TIVA) with Propofol/Remifentanil is preferred in many centres to reduce postoperative nausea, which is particularly important given arm positioning restrictions postoperatively.

• Enhanced Recovery After Surgery (ERAS) protocols—including multimodal analgesia (paracetamol + NSAIDs + regional nerve blocks such as medial cutaneous nerve of the forearm block), early mobilisation, and restrictive fluid management—are now standard in JCI-accredited centres in India and the UAE.

• Pneumatic compression devices (PCDs) and pharmacological DVT prophylaxis (low-molecular-weight heparin, e.g., enoxaparin 40 mg sc daily) are mandated from the time of surgery given prolonged positioning.

• Absorbable intradermal sutures (e.g., Monocryl 3-0 or 4-0) with tissue adhesive closure (Dermabond) are used to achieve a fine-line, tension-free scar.

PRE-OPERATIVE PHASE (4–8 Weeks Before Surgery):

• Virtual consultation with GAF Healthcare's surgical coordinator and the treating plastic surgeon; review of photographs and medical history

• Completion of all mandatory blood investigations, ECG, and imaging; results reviewed remotely by the surgical team

• Nutritional optimisation: post-bariatric patients are placed on high-protein supplementation (target ≥60–80g protein/day) and micronutrient repletion (iron, B12, folate, zinc, vitamin D) for a minimum of 4 weeks pre-operatively

• Smoking cessation confirmed ≥6 weeks pre-operatively

• Medical visa application initiated for India (e-Medical Visa) or UAE entry visa arranged by GAF Healthcare's logistics team

• Anaesthetic pre-assessment completed; ASA classification assigned

• Formal informed consent obtained via video-verified digital process

ARRIVAL (2–3 Days Before Surgery):

• GAF Healthcare airport transfer to partner hotel or hospital-linked accommodation

• In-person surgical consultation, physical examination, and standardised photography

• Final blood investigations and anaesthetic review at the hospital

• Surgical marking performed by the operating surgeon the evening before or morning of surgery

• NPO (nil per os) instructions: no food for 6 hours, no clear fluids for 2 hours prior to anaesthesia induction

INTRAOPERATIVE (Day 0 — 2–3 Hours):

• General anaesthesia induced; patient positioned supine with arms abducted at 90° on padded arm boards

• Tumescent infiltration (if combined with liposuction): 1:1,000,000 epinephrine in normal saline injected into the arm fat compartment

• Liposuction performed first (if indicated) using PAL or UAL; 15–20-minute waiting period for vasoconstriction effect

• Elliptical resection of excess skin and fat along the marked medial arm pattern; deep dissection preserves the medial brachial and medial cutaneous nerves and cephalic vein

• Multi-layer closure: deep fascial anchoring sutures, subcutaneous Vicryl, intradermal Monocryl, and tissue adhesive

• Compressive arm dressings applied; arm sleeves placed if not contraindicated

IMMEDIATE POST-OPERATIVE (Day 0–1):

• Recovery in PACU (Post-Anaesthesia Care Unit) for 1–2 hours; vital signs monitored continuously

• Multimodal analgesia initiated: regular paracetamol + ibuprofen (if no contraindication) + opioid rescue PRN

• Enoxaparin DVT prophylaxis commenced 6–12 hours post-operatively

• Most patients are discharged to hotel accommodation with a GAF Healthcare-assigned nurse escort after 1–2 overnight hospital observations

EARLY RECOVERY IN DESTINATION COUNTRY (Days 2–14):

• Day 3–5: First wound review; drain removal (if closed-suction drains were placed); wound inspection for seroma or haematoma

• Arms must be kept elevated above heart level when resting to minimise oedema during the first 7–10 days

• Compression garments (medical-grade, 20–30 mmHg) worn 23 hours/day for 6 weeks minimum

• Light activities of daily living (writing, gentle walking) permitted from Day 5–7; no lifting >0.5 kg for 4 weeks

• Day 10–14: Wound review by surgical team; scar assessment; sutures confirmed dissolved/absorbed; patient declared fit to fly if no complications are present (minimum 2 weeks for short-haul; 3 weeks for intercontinental)

LONG-TERM RECOVERY (Weeks 3–12 and Beyond):

• Week 3–6: Gradual return to office-based, sedentary work; avoid overhead arm movements and lifting

• Week 6: Compression garment requirement reassessed; most patients transition to lighter compression

• Week 8–12: Return to aerobic exercise (swimming, cycling) and progressively heavier upper body activities

• Month 3–6: Scar enters remodelling phase; topical silicone gel sheeting (e.g., Mepiform, Dermatix) recommended from Week 3 onwards; sun protection of the scar is mandatory for 12 months to prevent hyperpigmentation

• Month 12–18: Scar fully matures; residual widening or hypertrophy can be treated with fractional CO2 laser, intralesional triamcinolone, or surgical scar revision if indicated

• Remote follow-up at 1 month, 3 months, 6 months, and 12 months via GAF Healthcare's telemedicine platform